Literature DB >> 6777296

Mutation in the IA subregion of the murine H-2 complex.

I F McKenzie, M S Sandrin, G M Morgan, M M Henning, R W Melvold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777296     DOI: 10.1007/bf01567775

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  7 in total

1.  B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.

Authors:  I F McKenzie; G M Morgan; M S Sandrin; M M Michaelides; R W Melvold; H I Kohn
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

2.  The firstH- 2 mutant workshop.

Authors:  H I Kohn; J Klein; R W Melvold; S G Nathenson; D Pious; D C Shreffler
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

Review 3.  The protein products of the murine 17th chromosome: genetics and structure.

Authors:  E S Vitetta; J D Capra
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.

Authors:  D C Shreffler; C S David
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

6.  Evidence for more than one Ia antigenic specificity on molecules determined by the I-A subregion of the mouse major histocompatibility complex.

Authors:  S E Cullen; C S David; J L Cone; D H Sachs
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

7.  An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein A-bearing staphylococci.

Authors:  S E Cullen; B D Schwartz
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

  7 in total
  12 in total

1.  Studies of two H-2Db mutants: B6. C-H-2bm13 and B6.C-H-2bm14.

Authors:  G M Morgan; H Dellos; I F McKenzie; R W Melvold; D W Bailey
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

2.  The definition of a new Ia antigenic specificity using the B6.C-H-2bml2 I-region mutant strain.

Authors:  G M Morgan; I F McKenzie; R W Melvold
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

3.  Serological cross-reactivity between products of different Ia loci.

Authors:  P A Lowry; D B Murphy
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  A monoclonal antibody detecting an Ia specificity mapping in the I-A or I-E subregion.

Authors:  F W Symington; J Sprent
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Tryptic peptide comparison of Ia antigen alpha and beta polypeptides from the I-A mutant B6.C-H-2bm12 and its congenic parental strain B6.

Authors:  D J McKean; R W Melvold; C David
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Gene transfection of the HuLy-m2 (Leu-9) antigen into mouse L cells.

Authors:  M S Sandrin; K E Lovering; G Tachas; P R Collins; I F McKenzie
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Reconstitution of Ir genes, Ia antigens, and mixed lymphocyte reaction determinants by gene complementation.

Authors:  C G Fathman; M Kimoto; R Melvold; C S David
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  Selective loss of antigen-specific Ir gene function in IA mutant B6.C-H-2bm12 is an antigen presenting cell defect.

Authors:  C C Lin; A S Rosenthal; H C Passmore; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  T cell clones specific for hybrid I-A molecules. Discrimination with monoclonal anti-I-Ak antibodies.

Authors:  B N Beck; J G Frelinger; M Shigeta; A J Infante; D Cummings; G Hämmerling; C G Fathman
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Serologic and functional characterization of a panel of antigen-presenting cell lines expressing mutant I-A class II molecules.

Authors:  L H Glimcher; S O Sharrow; W E Paul
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.